Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a site maintenance/version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-03-21T00:53:38.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T19:22:16.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This appears to be a backend/UI version bump that does not modify the study content or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-02-13T12:17:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1, with no changes to study details or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:25:44.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Minor page revision: version updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:26:47.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Introduced a Locations section with Minnesota as a study site and removed the older Minnesota Locations entry and the HHS Vulnerability Disclosure link; page updated to revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T13:52:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.